60 Degrees Pharmaceuticals, Inc.
SXTP
$0.97
-$0.01-0.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.25% | 58.45% | -535.89% | -1.63% | -151.63% |
| Total Depreciation and Amortization | 55.10% | 79.09% | -23.98% | -32.05% | -42.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.73% | -92.08% | 111.24% | -72.12% | 113.33% |
| Change in Net Operating Assets | 39.51% | -79.16% | 393.94% | -83.27% | 89.57% |
| Cash from Operations | -25.45% | -22.04% | -40.07% | -2,471.74% | 55.21% |
| Capital Expenditure | 27.54% | 47.44% | -- | 100.00% | -666.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.11% | 89.16% | 17,500.00% | 80.56% | -6,539.46% |
| Cash from Investing | 98.54% | 60.41% | 17,472.45% | 96.85% | -6,160.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -16.76% | -100.00% | -9.90% | -- | -32.19% |
| Repurchase of Common Stock | -- | -- | -- | 32.78% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -32.11% | 251.28% |
| Cash from Financing | -16.85% | 100.00% | -10.84% | -- | -13.75% |
| Foreign Exchange rate Adjustments | -33.33% | 1,046.67% | -1,137.50% | -103.69% | -80.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.63% | -12.63% | 138.25% | -2,056.77% | -21.61% |